XML 18 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated statements of financial position - AUD ($)
Jun. 30, 2022
Jun. 30, 2021
Current assets    
Cash and cash equivalents $ 7,361,112 $ 27,586,760
Trade and other receivables 91,000 84,000
Other 156,000 1,720,000
Total current assets 7,608,000 29,391,000
Non-current assets    
Trade and other receivables 7,300,000 6,694,000
Intangibles 20,050,000 22,003,000
Total non-current assets 27,350,000 28,697,000
Total assets 34,958,000 58,088,000
Current liabilities    
Trade and other payables 3,760,000 4,933,000
Employee benefits 166,000 229,000
Contingent consideration 759,000 3,165,000
Total current liabilities 4,685,000 8,327,000
Non-Current liabilities    
Deferred tax 2,560,000 2,928,000
Employee benefits 319,000 55,000
Contingent consideration 8,756,000 8,927,000
Total non-current liabilities 11,635,000 11,910,000
Total liabilities 16,320,000 20,237,000
Net assets 18,638,000 37,851,000
Equity    
Contributed equity 84,480,249 80,290,062
Other contributed equity   464,000
Reserves 2,412,000 1,301,000
Accumulated losses (68,254,000) (44,204,000)
Equity attributable to the owners of Kazia Therapeutics Limited 18,638,000 37,851,000
Total equity $ 18,638,000 $ 37,851,000